Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Pre-sex HIV drug 'no-brainer" for NHS

Prep treatment could prevent a quarter of new HIV cases and save the NHS millions, experts calculate.

Published
16 hours ago
From
BBC Health
PrEP would save the NHS money, in numerous scenarios

A PrEP programme for men who have sex with men in the UK would not only be cost-effective, but actually cost-saving (in other words, both improving health

Published
17 October 2017
By
Roger Pebody
Gilead Continues To Block Ireland From Sourcing Generic Truvada

Gilead Sciences, the company that supplies Ireland with the drug Truvada, will have a full court hearing in mid-October to determine whether the Irish Health and Safety Executive (HSE) can source a generic analogue of the drug from the pharmaceutical giant’s competitors. In July, GCN reported that Gilead was taking legal action to stop the HSE from securing generic drug from Actavis and Mylan, the company’s competitors, for the purposes of HIV prevention as PrEP.

Published
16 October 2017
From
Gay Community News
MSM in London diagnosed with early syphilis are a priority group for PrEP, suggests UK study

Gay and other men who have sex with men (MSM) recently diagnosed with early syphilis are a priority group for HIV pre-exposure prophylaxis (PrEP), results of a

Published
16 October 2017
By
Michael Carter
PrEP activists warn new NHS trial will fail if black gay men don't take part

Sexual health campaigners are warning a newly launched trial in the UK will fail if not enough people of color take part, Gay Star News can reveal. The experts are estimating the overwhelming majority of the patients in the NHS trial will be white gay men. This could provide an unbalanced study with most of the evidence from just one group who could benefit from access to PrEP.

Published
13 October 2017
From
Gay Star News
Unpacking Michael Weinstein's Latest PrEP Denialism

The controversial head of the AIDS Healthcare Foundation has taken his PrEP-skepticism campaign to the prestigious medical journal AIDS. The editorial is compromised by unsound logic, the cherry picking of evidence and the tendency to ignore important granular details about HIV infection and PrEP-use trends.

Published
13 October 2017
From
Poz
England PrEP Impact Trial Launches

The England PrEP IMPACT Trial goes live tomorrow. Before you all go rushing out to your local sexual health clinic there are a few things we’d like to make you aware of. The trial team are expecting an initial surge for demand and clinics are doing their best to accommodate this. There are a few things we can do to help. Please try to wait until your regular clinic opens as part of the trial rather than register at a new clinic - though we completely understand that expecting people to wait for access to NHS PrEP is unacceptable to some. The trial team are pushing really hard for most of the 70 initial sites to be live as soon as possible with the remaining 130 clinics following quickly behind. Most clinics are expected to be up by the end of November and all by April 2018.

Published
11 October 2017
From
I Want PrEP Now
Reconsidering Primary Prevention: a Call To Action For The Global HIV Response

"The [HIV] prevention toolbox is getting bigger, but the application of the tools is getting smaller. For...prevention to stand a chance, the silence, denial, negativity, and moralism surrounding sex and drug use must end. Policy makers and donors, including governments, must shed their reluctance to openly and positively address sex and drug use in their public health discourse and responses to HIV."

Published
09 October 2017
From
MSMGF
Many gay/bisexual men currently taking PrEP would switch to injectable forms of the therapy should it become available

Approximately a third of gay and bisexual men who are currently taking oral (tenofovir/emtricitabine) pre-exposure prophylaxis (PrEP) would prefer long-acting injectable PrEP should it become

Published
09 October 2017
By
Michael Carter
New York City PrEP prescriptions increase nearly 1,000 percent, but disparities remain

New York City saw a 976 percent increase in PrEP prescriptions in two years, but disparities remain, according to an IDWeek study.

Published
09 October 2017
From
Eurekalert Inf Dis
← First12345...123Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.